To report the successful treatment of severe plaque psoriasis in a 61-year-old man undergoing peritoneal dialysis, who had a history of ESRD secondary to hypertension and type 2 diabetes mellitus.
Approach:
Initial Management: The patient was initially managed with topical corticosteroids and intensified dialysis, which provided transient improvement in psoriatic lesions.
Key Findings:
The patient achieved complete clearance of psoriatic lesions (PASI 0) by month 4 of secukinumab treatment.
Secukinumab treatment was well tolerated with no adverse events or complications related to peritoneal dialysis.
Interpretation:
This case supports the efficacy and safety of secukinumab for severe psoriasis in patients undergoing peritoneal dialysis, despite the lack of extensive evidence for this population.
Limitations:
The study is based on a single case report, limiting generalizability, and there is a lack of extensive evidence for secukinumab use in peritoneal dialysis patients.
Conclusion:
The management of severe psoriasis with secukinumab in this patient suggests a potential therapeutic option for similar cases.
